| Product Name | MF | CAS | Details |
|---|
| H-RWPSCQKKF-OH | Details |
| 7-Methoxy-2H-benzo[b][1,4]oxazin-3(4H)-one | C9H9NO3 | 6529-94-8 | Details |
| 7-Chloro-thieno[3,2-b]pyridine-2-carboxaldehyde | C8H4ClNOS | 387819-41-2 | Details |
| 2-(Amino)-2-methylbutanoic acid | C20H21NO4 | 160885-93-8 | Details |
| 2-(2-aza-2-(dimethylamino)-1-(4-methoxyphenyl)vinyl)indane-1,3-dione | C19H18N2O3 | 1024672-20-5 | Details |
| Carnegine hydrochloride | C13H20ClNO2 | 5852-92-6 | Details |
| Dicyclopropyl-1,3-thiazole-5-carboxylic acid | C10H11NO2S | 136204-56-3 | Details |
| (D-His2,D-Ser(tBu)6,Azagly10)-LHRH | C59H84N18O14 | 1926163-37-2 | Details |
| 7-Bromoimidazo[1,2-a]pyridin-2-yl trifluoromethanesulfonate | C8H4BrF3N2O3S | 1803605-72-2 | Details |
| L-threo-Phenylserine | C9H11NO3 | 6254-48-4 | Details |
| 2-Chloro-7-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | C9H7ClN2O | 17326-18-0 | Details |
| rac-(1R,2S)-2-[2-(Trifluoromethyl)phenyl]cyclopropan-1-amine hydrochloride | C10H11ClF3N | 175168-77-1 | Details |
| Evogliptin tartrate | C19H26F3N3O3 · (C4H6O6) | 1222102-51-3 | Details |
| 7-Cyclohexyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol | C14H19N3O | 103026-47-7 | Details |
| 5-(Bromomethyl)-1,3-dichlorobenzene | C7H5BrCl2 | 7778-01-0 | Details |
| L-Rhodinose | C6H12O3 | 35903-48-1 | Details |
| Telomerase antibody | Details |
| 5Fam-RHKK-OH | Details |
| PD1-PDL1 inhibitor 1 | C29H33NO5 | 1675201-83-8 | Details |
| Ethyl(1-phenylbutan-2-yl)amine | C12H19N | 119486-07-6 | Details |
| 2-Bromo-3-fluorophenylacetylene | C8H4BrF | 1855543-30-4 | Details |
| REXO2 protein (His tag) | Details |
| NAT2 Blocking Peptide | Details |
| H-LHGGSPWPPCQYR-OH | Details |
| 2-(1,4-Diazepan-1-yl)propan-1-ol | C8H18N2O | 1184691-34-6 | Details |
| Ac-STVHEILCKLSLEG-NH2 | Details |
| 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide | C14H18N2O2 | 1086394-87-7 | Details |
| 5-methoxynaphthalene-1-sulfonamide | C11H11NO3S | 32327-46-1 | Details |
| 4-Bromo-1-methyl-1H-imidazole-5-carbaldehyde | C5H5BrN2O | 141524-74-5 | Details |
| 4-Methyl-N-(propan-2-yl)aniline hydrochloride | C10H16ClN | 104294-53-3 | Details |
| 2-(5-Bromo-2,3-dihydro-1H-inden-1-yl)acetic acid | C11H11BrO2 | 87779-61-1 | Details |
| 3-[4-(1,3-Dioxolan-2-yl)oxan-4-yl]propan-1-amine | C11H21NO3 | 1354951-55-5 | Details |
| Rip1 kinase inhibitor 1 | C24H20ClN5O3 | 2095515-38-9 | Details |
| 2-[3-(Trifluoromethyl)phenyl]-1H-imidazole | C10H7F3N2 | 27423-80-9 | Details |
| TRH-SH Pro | C48H83N21O12S2 | Details |
| Cycloguanil hydrochloride | C11H14ClN5.ClH | 152-53-4 | Details |
| P12 amide | Details |
| 3-Bromo-6-fluoropyridine-2-carboxylic acid | C6H3BrFNO2 | 1211589-43-3 | Details |
| (1R,4aS,10aR)-9-Hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid | C20H28O4 | 155205-64-4 | Details |
| 4,6-Dimethyl-1,2,3,4-tetrahydroquinoline-8-carboxylic acid | C12H15NO2 | 1803598-24-4 | Details |
| 2,2-Difluoro-2-phenylethane-1-sulfonyl fluoride | C8H7F3O2S | 1989671-54-6 | Details |
| N-[(Thiophen-2-yl)methyl]pyridin-2-amine | C10H10N2S | 140-19-2 | Details |
| HNF1A Blocking Peptide | Details |
| CHRAC1 protein (His tag) | Details |
| H-GRTGRRNSI-NH2 | Details |
| IRAK4-IN-4 | C22H16N2O2 | 1850276-58-2 | Details |
| 3-(1-{[(tert-Butoxy)carbonyl]amino}cyclopentyl)prop-2-ynoic acid | C13H19NO4 | 2305255-33-6 | Details |
| 2-Methylpteridin-4-ol | C7H6N4O | 34244-78-5 | Details |
| MCL 0020 | C34H39N7O4 | 475498-26-1 | Details |
| (4R)-1-Boc-4-amino-3,3-difluoropiperidine ee | C10H18F2N2O2 | 1820679-70-6 | Details |
| 2-(3-Methyl-1,2,4-oxadiazol-5-yl)benzoic acid | C10H8N2O3 | 475105-77-2 | Details |
| N-Boc-2-(4'-Chlorophenyl)-L-glycine | C13H16ClNO4 | 917027-02-2 | Details |
| Ac-CDYEFEKHINLDQ-NH2 | Details |
| N-Phenylpyridin-4-amine | C11H10N2 | 22961-45-1 | Details |
| 2-Chloro-3-piperazin-1-yl-quinoxaline hydrochloride | C12H13ClN4.ClH | 55686-36-7 | Details |
| 4α,8β-Dihydroxyeudesm-7(11)-en-12,8α-olide | C15H22O4 | 1231208-53-9 | Details |
| VEGFR2 antibody (Tyr951) | Details |
| LRRC8E Blocking Peptide | Details |
| 3-(6-Oxo-1,6-dihydropyridazin-3-yl)benzoic acid | C11H8N2O3 | 1087379-58-5 | Details |
| 3-Amino-1-[4-(difluoromethoxy)phenyl]urea | C8H9F2N3O2 | 1094769-82-0 | Details |
| 2-{[1,2,4]Triazolo[4,3-a]pyridin-3-ylsulfanyl}acetic acid | C8H7N3O2S | 66234-67-1 | Details |
| N-(2-Aminoethyl)-N-ethylaniline dihydrochloride | C10H17ClN2 | 1089309-54-5 | Details |
| K6PP antibody | Details |
| Methyl 4-amino-6-tert-butylpyrimidine-2-carboxylate | C10H15N3O2 | 1513227-58-1 | Details |
| 4-Methyl-N-(piperidin-4-yl)-1,3-thiazole-5-carboxamide | C10H15N3OS | 1094477-20-9 | Details |
| Rilmenidine hemifumarate | 2C10H16N2O.C4H4O4 | 207572-68-7 | Details |
| 4-{5H,6H,7H,8H,9H,10H-[1,2,4]Triazolo[4,3-a]azocin-3-yl}aniline | C14H18N4 | 923803-82-1 | Details |
| 1,3-bis(4-methoxyphenyl)-5-((4-(dimethylamino)phenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione | C27H25N3O5 | 1023482-46-3 | Details |
| 2-[4-(Difluoromethyl)-6-(1,5-dimethyl-1H-pyrazol-4-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-1-yl]acetic acid | C15H15F2N5O2 | 1006477-98-0 | Details |
| 2-(N-Methyl4-bromobenzenesulfonamido)acetic acid | C9H10BrNO4S | 361374-14-3 | Details |
| 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | C9H9Cl2N | 61563-24-4 | Details |
| Hydroxy-(3,4,5-trifluoro-phenyl)-acetic acid methyl ester | C9H7F3O3 | 949167-51-5 | Details |
| 2,2-Dimethyl-3,4-dihydro-2H-1-benzopyran-8-amine | C11H15NO | 1486871-88-8 | Details |
| 2-Amino-2-phenyl-1-(piperidin-1-yl)ethan-1-one hydrochloride | 24185-34-0 | Details |
| {3-Oxa-6-azatricyclo[6.1.1.0,1,6]decan-4-yl}methanamine | C9H16N2O | 1989672-87-8 | Details |
| PEA15 antibody | Details |
| Macusine B | C20H25N2O+ | 6792-07-0 | Details |
| 4-Methyl-N-[2-(propan-2-yl)phenyl]-4,5-dihydro-1,3-thiazol-2-amine | C13H18N2S | 519150-64-2 | Details |
| FMO2 antibody | Details |
| Myozenin 1 antibody | Details |
| 2-Amino-5-bromo-3-ethylbenzoic acid | C9H10BrNO2 | 34921-61-4 | Details |
| 1-{12-Acetyl-8-thiatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}ethan-1-one | C16H12O2S | 35105-75-0 | Details |
| 2-Amino-4-methyl-2-phenylpentanoic acid hydrochloride | C12H17NO2.ClH | 2260936-59-0 | Details |
| Methyl (2E)-3-(4-bromo-2-fluorophenyl)prop-2-enoate | C10H8BrFO2 | 862651-19-2 | Details |
| 3-Methyl-3-azabicyclo[3.2.1]octan-8-amine dihydrochloride | C8H18Cl2N2 | 2173992-28-2 | Details |
| N-Cyclopentyl-2-(piperidin-4-yl)acetamide | C12H22N2O | 1016770-49-2 | Details |
| N-benzo[3,4-d]1,3-dioxolen-5-yl(3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)formamide | C18H12Cl2N2O4 | 354544-76-6 | Details |
| Oxamarin | C22H34N2O4 | 15301-80-1 | Details |
| Pethoxamid | C16H22ClNO2 | 106700-29-2 | Details |
| 4-[(3-Methylpiperidin-1-yl)sulfonyl]benzoic acid | C13H17NO4S | 70111-46-5 | Details |
| tert-Butyl N-({4-amino-3,3-dimethyl-2-oxabicyclo[2.1.1]hexan-1-yl}methyl)carbamate | C13H24N2O3 | 2228650-11-9 | Details |
| 3-(Hydroxymethyl)azepan-2-one | C7H13NO2 | 1781900-59-1 | Details |
| 4,6-Diazaspiro[2.4]heptane-5,7-dione | C5H6N2O2 | 99420-34-5 | Details |
| CYP4X1 Blocking Peptide | Details |
| (αR, βS)-4-Hydroxy-β-methyl-4-phenyl-α-[4-(phenylmethoxy)phenyl]-1-piperidineethanol | C27H31NO3 | 571178-31-9 | Details |
| Lisdexamfetamine dimesylate impurity C | Details |
| 2-(3-Cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methylpiperazine dihydrochloride | C10H17ClN4O | 1803605-20-0 | Details |
| Oct4 | Details |
| IDX 320 | C37H43F3N6O7S2 | 1251165-81-7 | Details |
| 1-Sulfanyl-4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-4-one | C9H6N4OS | 540760-27-8 | Details |
| Product Total： Product Page： | ||||
| 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 | ||||